Newer fluoroquinolones and the management of respiratory tract infections

Clinical Infectious Diseases

Volumn 31, Issue SUPPL. 2, 2000, Pages

  Karchmer, A W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG INDICATION; DRUG SAFETY; HAEMOPHILUS INFLUENZAE; HUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HUMANS; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS;

EID: 17544394421     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/314055     Document Type: Conference Paper

References (2)

1. Achievements in public health, 1900-1999: Control of infectious diseases
2. The cost of treating community-acquired pneumonia